Hydrocortisone Butyrate

Especificaciones

13609-67-1Número CAS

237-093-4Número CE

[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoateNombre IUPAC

C25H36O6Fórmula química

432.5 g/molPeso molecular

hydrocortisone butyrate; Hydrocortisone 17-butyrate; 13609-67-1; Cortisol 17-butyrate; Locoid; Hydrocortisone-17-butyrate; Hydrocortisone-17alpha-butyrate; Locoid Lipocream; 17-O-butyrylcortisol; DTXSID4045896; 05RMF7YPWN; H-17-B; 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate; CHEBI:31674; NSC-758433; 11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate; DTXCID2025896; 11-beta,17-alpha,21-Trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate; 11beta,21-dihydroxy-17alpha-butyryloxy-4-pregnene-3,20-dione; Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11beta)-; Locoid crelo; Aquax-H; RefChem:55348; 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butanoate; 237-093-4; MLS000028716; Laticort; [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate; Alfason; Hycortate; Lacoidon; SMR000058859; Bucort; Lacoid; (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl butyrate; MFCD00083364; HB(sub 17); (1S,10S,11S,15S,17S,2R,14R)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-ox otetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl butanoate; CAS-13609-67-1; CORTISOL, 17-BUTYRATE; H.17B; EINECS 237-093-4; UNII-05RMF7YPWN; BMCQMVFGOVHVNG-TUFAYURCSA-N; NCGC00095037-01; locoid (TN); Cortisol 17-butyrate;Hydrocortisone butyrate; hydrocortisone-butyrate; Opera_ID_188; Hydrocortisone butyrate [USAN:USP:BAN:JAN]; Epitope ID:119710; Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11-beta)-; SCHEMBL4695; CHEMBL1683; MLS001076086; MLS002207122; orb1226451; HY-B0983R; MSK2249; BDBM323672; HMS2231B16; HY-B0983; Tox21_111397; AC-492; EBC-17105; Hydrocortisone butyrate (JP18/USP); HYDROCORTISONE BUTYRATE [JAN]; MSK2249-100M; s6590; HYDROCORTISONE BUTYRATE [USAN]; AKOS015895443; Hydrocortisone 17-butyrate (Standard); MSK2249-1000M; Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11.beta.)-; Tox21_111397_1; CS-4474; DB14540; HYDROCORTISONE BUTYRATE [MART.]; HYDROCORTISONE BUTYRATE [VANDF]; NSC 758433; HYDROCORTISONE BUTYRATE [USP-RS]; HYDROCORTISONE BUTYRATE [WHO-DD]; HYDROCORTISONE 17-BUTYRATE [MI]; NCGC00274077-01; US10188667, Example 00013; US10188667, Example 00024; (1R,3aS,3bS,9aR,9bS,10S,11aS)-10-hydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl butanoate; FH167414; ST075194; H1506; HYDROCORTISONE BUTYRATE [ORANGE BOOK]; NS00015430; D01619; HYDROCORTISONE BUTYRATE [USP MONOGRAPH]; EN300-7403907; Q5954743; BRD-K99199077-001-16-1; Hydrocortisone Butyrate (Hydrocortisone 17-Butyrate); Hydrocortisone 17-butyrate Solution in Methanol, 100ug/mL; Hydrocortisone 17-butyrate Solution in Methanol, 1000ug/mL; 11.BETA.,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE 17-BUTYRATE; Hydrocortisone butyrate, United States Pharmacopeia (USP) Reference Standard; "MLS001076086-01!11BETA,17,21-TRIHYDROXYPREGN-4-ENE-3,20-DIONE 17-BUTYRATE"; (8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl butanoateSinónimos